Skip to main content
Erschienen in: Clinical Oral Investigations 5/2019

09.10.2018 | Original Article

Yes-associated protein (YAP) molecule expression in odontogenic epithelium of ameloblastoma

verfasst von: Rahul Anand, Sachin C. Sarode, Gargi S. Sarode, Ladu Singh Rajpurohit, Shankargouda Patil

Erschienen in: Clinical Oral Investigations | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

YAP (Yes-associated protein molecule) augments multiple processes known to be important for tumor progression and metastasis. Hence, the application of YAP as a targeted therapy for several malignancies has been documented in the literature. Ameloblastoma being a locally invasive odontogenic lesion causes tissue destruction and presents with a great chance of recurrence. Based on these qualities, we hypothesized that YAP could exhibit increased expression in the odontogenic epithelium of ameloblastoma. Therefore, the objective of the present study was to evaluate the immunohistochemical expression of YAP in ameloblastoma and compare the immunoreactivity of YAP in ameloblastoma and dental follicle.

Materials and methods

Twenty-four paraffin-embedded tissue blocks of ameloblastoma and dental follicle each were retrieved from the departmental archives. Immunohistochemical (IHC) staining was performed employing YAP antibody on 5-μm thick sections. The expression of YAP was reviewed on the peripheral lining of ameloblast-like cells and centrally placed stellate reticulum–like cells and was further graded as negative, weak, or strong. For data analysis, Chi-square test and Fisher’s exact test were applied.

Results

In ameloblastoma, peripheral/basal cells exhibited strong expression for YAP in 12/24 cases and weak expression in the other 12 cases. Whereas, 20 cases of dental follicle presented negative expression and only four cases exhibited weak expression (p < 0.001). On statistical analysis, the differences in expression of YAP in stellate cells of ameloblastoma and dental follicle were found to be significant (p < 0.001).

Conclusion

YAP expression was strongly seen in ameloblastoma as compared to the epithelial islands of dental follicle. The neoplastic nature of ameloblastoma could be attributed to YAP molecule and it may play a possible role in tumor invasiveness.

Clinical relevance

Positive YAP expression in ameloblastoma and negative expression in the odontogenic epithelial islands of dental follicle insinuate that YAP could be responsible for the aggressiveness and local tissue invasion commonly encountered with ameloblastoma.
Literatur
1.
Zurück zum Zitat Lagares DT, Cossío PI, Guisado JMH, Pérez JLG (2005) Mandibular ameloblastoma. A review of the literature and presentation of six cases. Med Oral Patol Oral Cir Bucal 10:231–238 Lagares DT, Cossío PI, Guisado JMH, Pérez JLG (2005) Mandibular ameloblastoma. A review of the literature and presentation of six cases. Med Oral Patol Oral Cir Bucal 10:231–238
2.
Zurück zum Zitat Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Coleman H (2005) Ameloblastomas. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) Pathology and genetics of head and neck tumors. Odontogenic tumors, World Health Organization Classification of Tumors. IARC Press, Lyon, pp 296–300 Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Coleman H (2005) Ameloblastomas. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) Pathology and genetics of head and neck tumors. Odontogenic tumors, World Health Organization Classification of Tumors. IARC Press, Lyon, pp 296–300
3.
Zurück zum Zitat Reichart PA, Philipsen HP, Sonner S (1995) Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 31B:86–99CrossRefPubMed Reichart PA, Philipsen HP, Sonner S (1995) Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 31B:86–99CrossRefPubMed
4.
Zurück zum Zitat Reichart PA, Philipsen HP (eds). Odontogenic tumors and allied lesions. Quintessence Int 2004:43–48 Reichart PA, Philipsen HP (eds). Odontogenic tumors and allied lesions. Quintessence Int 2004:43–48
5.
Zurück zum Zitat Harvey K, Tapon N (2007) The Salvador-Warts-Hippo pathway: an emerging tumor-suppressor network. Nat Rev Cancer 7:182–191CrossRefPubMed Harvey K, Tapon N (2007) The Salvador-Warts-Hippo pathway: an emerging tumor-suppressor network. Nat Rev Cancer 7:182–191CrossRefPubMed
6.
Zurück zum Zitat Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962–1971CrossRefPubMedPubMedCentral Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962–1971CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Tapon N, Harvey KF, Bell DW, Wahrer DCR, Schiripo TA, Haber DA, Hariharan IK (2002) Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110:467–478CrossRefPubMed Tapon N, Harvey KF, Bell DW, Wahrer DCR, Schiripo TA, Haber DA, Hariharan IK (2002) Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110:467–478CrossRefPubMed
8.
Zurück zum Zitat Soini Y, Puhakka A, Kahlos K, Säily M, Pääkkö P, Koistinen P et al (2001) Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1. Histopathol 39:179–186CrossRef Soini Y, Puhakka A, Kahlos K, Säily M, Pääkkö P, Koistinen P et al (2001) Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1. Histopathol 39:179–186CrossRef
9.
Zurück zum Zitat Zhang L, Ye DX, Pan HY, Wei KJ, Wang LZ, Wang XD, Shen GF, Zhang ZY (2011) Yes-associated protein promotes cell proliferation by activating Fos related Activator-1 in oral squamous cell carcinoma. Oral Oncol 47:693–697CrossRefPubMed Zhang L, Ye DX, Pan HY, Wei KJ, Wang LZ, Wang XD, Shen GF, Zhang ZY (2011) Yes-associated protein promotes cell proliferation by activating Fos related Activator-1 in oral squamous cell carcinoma. Oral Oncol 47:693–697CrossRefPubMed
10.
Zurück zum Zitat Muramatsu T, Imoto I, Matsui T, Kozaki KI, Haruki S, Sudol M et al (2010) YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 32:389–398CrossRefPubMed Muramatsu T, Imoto I, Matsui T, Kozaki KI, Haruki S, Sudol M et al (2010) YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 32:389–398CrossRefPubMed
11.
Zurück zum Zitat Fernandez LA, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S et al (2009) YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev 23:2729–2741CrossRef Fernandez LA, Northcott PA, Dalton J, Fraga C, Ellison D, Angers S et al (2009) YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev 23:2729–2741CrossRef
12.
Zurück zum Zitat Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65:7561–7567CrossRefPubMed Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65:7561–7567CrossRefPubMed
13.
Zurück zum Zitat Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC et al (2005) Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24:4232–4242CrossRefPubMed Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC et al (2005) Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24:4232–4242CrossRefPubMed
14.
Zurück zum Zitat Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EFPM, Massimino M, Sozzi G (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223–5233CrossRefPubMed Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EFPM, Massimino M, Sozzi G (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223–5233CrossRefPubMed
15.
Zurück zum Zitat Xu MZ, Yao TJ, Lee P, Ng IO, Chan YT, Zender L et al (2009) Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115:4576–4585CrossRefPubMed Xu MZ, Yao TJ, Lee P, Ng IO, Chan YT, Zender L et al (2009) Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115:4576–4585CrossRefPubMed
16.
Zurück zum Zitat Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, del Sal G (2014) Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol 16:357–366CrossRefPubMed Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, del Sal G (2014) Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol 16:357–366CrossRefPubMed
Metadaten
Titel
Yes-associated protein (YAP) molecule expression in odontogenic epithelium of ameloblastoma
verfasst von
Rahul Anand
Sachin C. Sarode
Gargi S. Sarode
Ladu Singh Rajpurohit
Shankargouda Patil
Publikationsdatum
09.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 5/2019
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-018-2693-6

Weitere Artikel der Ausgabe 5/2019

Clinical Oral Investigations 5/2019 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.